Rossari Biotech Ltd

BSE
ROSSARI •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Rossari Biotech Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Mar 26, 2024
10.2
TTM PE Ratio
Below industry Median
33.9
Price to Book Ratio
Below industry Median
4.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
1.6
RSI
RSI is mid-range
52.1
MFI
MFI is mid-range
41.6

Rossari Biotech Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Rossari Biotech Ltd shareholding Pattern

Promoter
68.3%
Foreign Institutions
4%
Mutual Funds
13.3%
Domestic Institutions
17.7%
Public
9.9%
Promoter
68.3%
Foreign Institutions
4.1%
Mutual Funds
13.9%
Domestic Institutions
18.1%
Public
9.4%
Promoter
68.4%
Foreign Institutions
5.7%
Mutual Funds
14.4%
Domestic Institutions
17.7%
Public
8.2%
Promoter
68.4%
Foreign Institutions
6.1%
Mutual Funds
15.4%
Domestic Institutions
17.7%
Public
7.7%
Promoter
68.4%
Foreign Institutions
7.5%
Mutual Funds
13.1%
Domestic Institutions
15.1%
Public
9%
Promoter
68.4%
Foreign Institutions
8.6%
Mutual Funds
12.6%
Domestic Institutions
14.1%
Public
8.8%

Rossari Biotech Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
811.20
10Day EMA
813.00
12Day EMA
812.30
20Day EMA
804.80
26Day EMA
797.40
50Day EMA
774.90
100Day EMA
760.10
200Day EMA
762.40
5Day SMA
812.60
10Day SMA
813.10
20Day SMA
819.00
30Day SMA
791.90
50Day SMA
753.30
100Day SMA
739.60
150Day SMA
754.90
200Day SMA
758.30
Delivery & Volume
Resistance & Support
801.52
Pivot
Resistance
First Resistance
811.73
Second Resistance
822.27
Third Resistance
832.48
Support
First Support
790.98
Second support
780.77
Third Support
770.23
Relative Strength Index
52.09
Money Flow Index
41.55
MACD
14.92
MACD Signal
20.50
Average True Range
24.33
Average Directional Index
21.53
Rate of Change (21)
4.81
Rate of Change (125)
2.27
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
NOCIL Ltd.
4875.22
208
319
Styrenix Performance Materials Ltd.
4324.68
952.05
2729
Fineotex Chemical Ltd.
4001.94
266.05
458
Privi Speciality Chemicals Ltd.
5817.61
975
1679
Neogen Chemicals Ltd.
4116.73
1148.8
1851.05
Epigral Ltd.
5877.27
870
1582.1

Rossari Biotech Ltd Company background

Founded in: 2009
Managing director: Sunil Chari
Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both careertechnocrats cumulatively having over 45 years of experience in the specialty chemicals industry. It was further renamed to Rossari Biotech Limited and converted into a company in 2009. The Company has two stateofthe art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumercentric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was subdivided into 2,50,00,000 Equity Shares of face value of Rs 2 each. Accordingly 4,400,000 paidup equity shares of face value of Rs 10 each was split into 22,000,000 Equity Shares of face value of Rs 2 each.The Company has issued and allotted 2,64,00,000 Equity Shares of face value of Rs 2/ each to the eligible Members of the Company in the ratio of 6(Six) Equity share for every 5 (Five) Equity shares, as Bonus Equity shares. During the year 201920, in compliance with the provisions of Sections 42 62 of the Act and Rules made thereunder, the Company has issued and allotted 23,52,920 Equity Shares of face value of Rs 2/ each to the eligible Qualified Institutional Buyers at issue price of Rs 425/ per Equity Share i.e. at a premium of Rs 423/ per Equity Share aggregating to Rs 99,99,91,000 /on preferential basis through private placement.During the second quarter of FY2021,the Company has completed Initial Public Offer (IPO) of 11,676,470 Equity Shares of the face value of Rs. 2/ each at an issue price of Rs. 425/ per Equity Share, comprising offer for sale of 10,500,000 shares by Selling Shareholders and fresh issue of 1,176,470 shares. The Equity Shares of the Company were listed on 23 July 2020 on Bombay Stock Exchange and National Stock Exchange of India Limited.The Company has a wholly owned subsidiary, Rossari Personal Care Products Private Limited (Formerly known as Neutron Impex Private Limited) which was engaged in the business of manufacturing, exporting and importing specialty chemicals, dyes, etc. upto 31 March 2015. The Company has also acquired a Joint Venture (JV) company, Buzil Rossari Private Limited, engaged in the business of providing Trading of specialty chemicals. Buzil Rossari Private Limited (BRPL) became a wholly owned subsidiary of the Company w.e.f. 31 August 2020.During the year ended on 31 March, 2021, the Board of Directors at its meeting held on 23 March, 2021, has approved the issue of 3,012,046 equity shares on preferential basis for cash consideration . Subsequent to year ended 31March, 2021, the shareholders of the Company at its Extra Ordinary General meeting held on 17April, 2021 has approved issue of 3,012,046 shares of face value of Rs. 2 each on preferential basis at price of Rs. 996 per share aggregating to Rs. 3000.00 million. The allotment of the shares of the Company has been completed on 21April, 2021.Pursuant to the lockdowns by the central and state government authorities to contain the spread of COVID19 outbreak, the Companys operations and financial results for the year have been impacted. The operations gradually resumed in a phased manner with requisite precautions during the year ended 31 March, 2021. Company achieved the full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat on 31st March, 2021.During the quarter ended 30 June, 2021, the Company at the meeting of the Board of Directors held on 02 June, 2021 has agreed to acquire 100% of shareholding of Unitop Chemicals Private Limited at an aggregate consideration of Rs. 4,210 million from the existing shareholders in multiple tranches, subject to completion of the customary terms and conditions.Also Subsequent to the quarter ended 30 June, 2021, the Company at the meeting of the Board of Directors held on 17 July, 2021 has agreed to acquire 100% shareholding of Tristar Intermediates Private Limited at an aggregate consideration of Rs. 1,200.00 million from the existing shareholders in multiple tranches, subject to completion of the customary terms and conditions.Further, subsequent to quarter ended 30 June, 2021, the Company at its meeting of the Board of Directors held on 30 July 2021 has resolved to make a strategic investment by acquiring and/or subscribing to equity shares equivalent to 50.10% of the issued and paidup share capital of Romakk Chemicals Private Limited (Romakk) at an aggregate consideration of Rs. 75.10 million.Subsequent to the quarter ended 30 June 2021, the Company has acquired balance 40% stake in its subsidiary Rossari Personal Care Products Private Limited for aggregate consideration of Rs. 20.00 million making it a wholly owned subsidiary of the Company.Solar Panel was Installed at Dahej Plant to accommodate 1 MW Solar Power Installation in FY22. Total Energy Savings in FY2122 was 50 KVA. During the Financial Year 202122, the Company announced strategic acquisitions of three highquality and high potential companies in the Speciality Chemical space viz. Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, and Romakk Chemicals Private Limited. Strategic investment in Unitop Chemicals, Tristar Intermediates and Romakk Chemicals unlocked significant cross selling opportunities. A new line of products based on polyester chemistry was developed and ramped up at Rossaris Dahej facility, addressing a key product gap in textile portfolio for the sizing of market in polyester and cotton fabric. RD introduced green products in newer divisions to reduce high TDS and save energy by designing products that work at lower temperatures. The Sustainable dyeing, programmed for blacks, using Green Chemistry, has been successful on knit fabric and is generating good interest from big brands. During 202122, the Company acquired a controlling stake in Unitop Chemicals. It acquired Tristar Intermediates, aroma chemicals, and home and personal care additives with hightech distillation facilities. It completed the integration of Romakk Chemicals during FY22, acquiring a 50.1% stake in the company. During FY 202223, the Company acquired additional stake of 15% in Unitop Chemicals Pvt Ltd (UCPL) and 8% in Tristar Intermediates Pvt Ltd., taking the Companys holding to 80% and 84%, respectively. Also, the Company has acquired the remaining 16% stake in TIPL after the end of the Financial Year 202223.
Read More

Rossari Biotech Ltd FAQs

The past 1-year return of Rossari Biotech Ltd [ROSSARI] share was -10.18. The Rossari Biotech Ltd [ROSSARI] share hit a 1-year low of Rs. 657.8 and a 1-year high of Rs. 900.

The Mutual Fund Shareholding was 13.27% at the end of .

You can easily buy Rossari Biotech Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -